VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ABBV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ABBVAbbVie Inc.
$254.76$450.1B
Overview & Verdict
OverviewShould I Buy?
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksABBVPrice Target
ABBV logo

AbbVie Inc. (ABBV) Price Target Analysis

Updated Jul 2, 2026
Analyst Rating: Buy
Based on 41 analysts

1.3% Below Target

ABBV trades 1.3% below Wall Street's consensus target of $258.00.

Current Price$254.76
Average Target$258.00
Target
Current
Low$223.00
Median$260.00
High$298.00

Analyst Target Range

Forward P/E17.9x
(Fair)
PEG Ratio—
Implied Growth+593.6%
(High Growth)
Analyst Spread29.1%
(High Agreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$254.76
Consensus$258.00
High$298.00
Low$223.00

Consensus Scenario Assumptions

The base valuation assumes ABBV achieves its forward estimates and maintains a stable P/E multiple of 17.9x. This scenario reflects the blended consensus of 41 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 41 published analyst recommendations for ABBV

28/41 analysts are bullish
+33
BearishBullish
Weighted analyst sentiment score based on 41 ratings
ConsensusBuy
Coverage41 Analysts
Net Score+33
Bull / Bear68% / 2%
Strong Buy00%
Buy2868%
Hold1229%
Sell12%
Strong Sell00%
Strong Buy
00%
Buy
2868%
Hold
1229%
Sell
12%
Strong Sell
00%
Recommendation Mix68% Buy · 29% Hold · 2% Sell
Buy (28)Hold (12)Sell (1)

ABBV Price Target Analysis

Updated July 7, 2026

As of July 7, 2026, AbbVie Inc. (ABBV) has a Wall Street consensus price target of $258.00, based on estimates from 41 covering analysts. With the stock currently trading at $254.76, this represents a potential upside of +1.3%. The company has a market capitalization of $450.11B.

Analyst price targets range from a low of $223.00 to a high of $298.00, representing a 29% spread in expectations. The median target of $260.00 aligns closely with the consensus average.

The current analyst consensus rating is Buy, with 28 analysts rating the stock as a Buy or Strong Buy,12 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.

From a valuation perspective, ABBV trades at a trailing P/E of 107.5x and forward P/E of 17.9x. Analysts expect EPS to grow +593.6% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $392.79, with bear and bull scenarios of $247.46 and $517.54 respectively. Model confidence stands at 55/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+10.6%
Industry Consensus
Avg Forward P/E
16.9x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
JNJ logo
JNJJohnson & Johnson
$624.3B$259.33$253.42
-2.3%
Buy22.4x40
MRK logo
MRKMerck & Co., Inc.
$313.1B$126.78$133.77
+5.5%
Buy24.7x37
PFE logo
PFEPfizer Inc.
$134.9B$23.72$26.75
+12.8%
Hold8.0x39
BMY logo
BMYBristol-Myers Squibb Company
$115.8B$56.70$62.60
+10.4%
Hold9.0x41
LLY logo
LLYEli Lilly and Company
$1.1T$1200.06$1269.94
+5.8%
Buy32.8x45
AMGN logo
AMGNAmgen Inc.
$197.8B$366.44$352.50
-3.8%
Buy16.4x38
GILD logo
GILDGilead Sciences, Inc.
$160.9B$129.61$161.81
+24.8%
Buy—58
BIIB logo
BIIBBiogen Inc.
$30.8B$208.46$218.32
+4.7%
Buy14.4x48
REGN logo
REGNRegeneron Pharmaceuticals, Inc.
$67.5B$649.81$836.00
+28.7%
Buy14.0x48
SNY logo
SNYSanofi
$102.4B$42.61$51.00
+19.7%
Hold10.1x27

ABBV — Frequently Asked Questions

Quick answers to the most common questions about buying ABBV stock.

What is the ABBV stock price target for 2026?

The consensus price target for ABBV is $258, close to the current price of $254.76 (1.3% implied move). Based on 41 analyst estimates, the stock appears fairly valued near current levels.

Is ABBV a buy, sell, or hold?

ABBV has a consensus rating of "Buy" based on 41 Wall Street analysts. The rating breakdown is predominantly bullish, with 28 Buy/Strong Buy ratings. The consensus 12-month price target of $258 implies 1.3% upside from current levels.

Is ABBV stock overvalued or undervalued?

With a forward P/E of 17.9049x, ABBV trades at a relatively low valuation. The consensus target of $258 implies 1.3% appreciation, suggesting the market may be pricing in risks.

How high can ABBV stock go?

The most bullish Wall Street analyst has a price target of $298 for ABBV, while the most conservative target is $223. The consensus of $258 represents the median expectation. Our quantitative valuation model projects a bull case target of $518 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover ABBV stock?

ABBV is heavily covered by Wall Street, with 41 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 28 have Buy ratings, 12 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the ABBV stock forecast?

The 12-month ABBV stock forecast based on 41 Wall Street analysts shows a consensus price target of $258, with estimates ranging from $223 (bear case) to $298 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $393, with bear/bull scenarios of $247/$518.

What is ABBV's fair value based on fundamentals?

Our quantitative valuation model calculates ABBV's fair value at $393 (base case), with a bear case of $247 and bull case of $518. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 55/100.

What is ABBV's forward P/E ratio?

ABBV trades at a forward P/E ratio of 17.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 107.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy ABBV stock?

ABBV appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $258 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do ABBV price targets vary so much?

ABBV analyst price targets range from $223 to $298, a 29% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $258 consensus represents the middle ground. Our model's $247-$518 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Should I Buy ABBV?

Wall Street verdict, signals, and target summaries.

See Verdict

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare